In this study, we investigated ITH, using AI and digital pathology technology for interpretable features, in a large cohort of luminal (ER and progesterone receptor (PR) positive and human epidermal growth factor 2 (HER2) negative) BC to eliminate the impact of molecular subtype on the morphologic features of the tumors. This evidence concerns the gene PGR and breast cancer.